Pharmaceutical compositions relating to vasoactive intestinal polypeptides
and methods for the treatment of metabolic disorders, including diabetes,
insulin resistance, metabolic acidosis and obesity are presented. Methods
of using the vasoactive intestinal polypeptide compositions are also
disclosed.